that specifically targets the alpha(5)beta(1) integrin which is over-expressed in a variety of cancer cells and on tumor vasculature
Story Title | Content type | Authored by | Authored on |
---|---|---|---|
Bioengineering Seminar Series | Event | Colly Mitchell |
Thursday, May 22, 2025
Story Title | Content type | Authored by | Authored on |
---|---|---|---|
Bioengineering Seminar Series | Event | Colly Mitchell |